The FANCL gene helps cells repair damage to DNA, especially damage that can happen as cells copy their genetic material. If this repair system does not work well, cells may break down or die more easily, which can affect blood production and raise the chance of some cancers. Pathogenic variants in both copies of the FANCL gene can cause Fanconi anemia, a condition that may involve low blood counts, growth differences, and congenital features. FANCL is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate what happens in the body. Some provide the code for proteins, which are the active parts of cells. Others mostly direct when specific processes happen, where they take place, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you react to food, stress, and medications. For a deeper look at this topic, see the LearnHub.
Overview
FANCLGene function
What if the gene works
The FANCL gene helps cells repair certain types of DNA damage, especially damage that links the two DNA strands together. This supports normal cell growth and helps protect blood, bone marrow, and other fast growing tissues.
Risk
What if the gene does not work
Variants in the FANCL gene can cause Fanconi anemia, often with low blood counts, growth or limb differences, and higher leukemia risk. Milder or more severe variants may affect when signs appear and how much the condition affects someone.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss-of-function variant in the FANCL gene, no FANCL-specific treatment or management approach is currently established. In research, the FANCL gene is being studied as part of the Fanconi anemia repair pathway and as a possible biomarker for how some cancers respond to certain chemotherapy drugs.
Conditions associated with FANCL
Gene function
What if the gene works
The FANCL gene helps your cells look after their DNA during everyday life. It is part of a repair team that turns on the right fix for certain types of DNA damage. Understanding how the FANCL gene helps repair DNA makes its role in normal cell function easier to picture. When this process runs smoothly, cells can copy their DNA in a more orderly way.
FANCL helps cells respond to DNA damage that links the two DNA strands together. This kind of damage can block normal DNA copying, so the repair response helps the cell move forward safely.
FANCL places a small protein tag on FANCD2 and FANCI, two important repair helpers. That tag acts like an on switch, telling the Fanconi repair pathway to get to work.
During cell growth, FANCL supports repair while DNA is being copied before division. This helps cells finish copying with fewer interruptions and keeps the process more organized.
By coordinating these repair steps, FANCL helps protect the structure of chromosomes, which are packages of DNA. This supports steady cell renewal and healthy everyday function in many tissues.
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FANCL gene can change the shape or stability of its protein, weaken its ability to attach ubiquitin (a small cellular tag) to key DNA repair partners, or disrupt how it joins the Fanconi anemia repair complex. In practical terms, this is how FANCL gene variants affect protein function at the cell level. Milder variants may leave some activity, while more disruptive variants can sharply reduce it, which often links to earlier or more pronounced features of Fanconi anemia.
How variants are linked to conditions
Pathogenic variants in the FANCL gene can cause Fanconi anemia, a rare inherited condition that may affect blood cell production, growth, and several body systems. In practice, FANCL gene variants linked to Fanconi anemia are usually found when a person has features such as low blood counts, birth differences, or unusually early bone marrow problems. People with this diagnosis may also have a higher chance of leukemia and some solid tumors over time.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FANCL, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having Fanconi anemia is much higher when both parents carry a harmful FANCL change, and this is more likely in families with a known history of the condition or when parents are blood relatives.
Inheritance of FANCL variants
FANCL-related Fanconi anemia is inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing FANCL variants, one from each parent. Parents who each carry one FANCL variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither familial variant. Because the FANCL gene is on an autosome, this inheritance pattern is the same for males and females.
What does my FANCL result mean for my family?
For families with a FANCL-related condition, close relatives may also carry the same gene change. Brothers and sisters may have the condition or be carriers, and parents are usually carriers without having symptoms themselves. Other blood relatives may also be carriers, so the result can matter beyond one person in the family.
Genetic information
Genetic testing
How you find out about variants
FANCL genetic testing looks for variants in the FANCL gene using a blood sample, saliva, or sometimes a cheek swab. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present, which can help clarify a suspected inherited condition or carrier status.
When should I consider getting a genetic test?
Genetic testing for the FANCL gene may be worth considering when there are signs of Fanconi anemia, such as very low blood counts, the bone marrow not making enough blood cells, certain birth differences, or a known family history of this condition. It can also help when a close relative is known to carry a FANCL change.
A genetic result is only one part of your health story
A genetic test result can give useful insight, although what it can tell you varies with the condition and the specific variant. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. In some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. For topics like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how a person responds to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medication works well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are one part of the broader picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support better informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the FANCL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have concerns about side effects, a medicine not working as expected, or questions about how your health condition may affect treatment, it is best to discuss them with your doctor.
History
Fanconi anemia was first described in 1927 by Swiss pediatrician Guido Fanconi, long before the individual genes behind it were known. Inheritance patterns were noticed long before the gene was identified. As researchers sorted patients into different Fanconi anemia subtypes, the FANCL gene was recognized as the cause of the FA-L complementation group, adding another piece to this inherited condition’s puzzle. Its discovery helped expand the map of Fanconi anemia genes during the years when DNA testing was becoming more precise. From these first observations, research expanded steadily, and FANCL became part of the broader story of how scientists uncovered the network of genes involved in this condition.